Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03858153 · ClinicalTrials.gov registry record · Phase 2
Exercise and Nutrition Interventions During Chemotherapy K07
A Phase 2 study of Neuropathy;Peripheral, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT03858153 is a Phase 2 study of Neuropathy;Peripheral that has completed, run by University of Rochester. The registered enrollment target is 80 participants, above the 31-participant average among 6 other Neuropathy;Peripheral trials with a reported enrollment target (158% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT03858153, a Phase 2 study of Neuropathy;Peripheral, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of taxane chemotherapy, often used to treat breast cancer. Unfortunately there are very limited treatments for CIPN. This is a phase II randomized controlled trial to test the preliminary efficacy of exercise vs. nutrition education on CIPN, to systematically investigate the potential roles of inflammation and interoception, and to obtain data with a more accurate effect size to inform a future study.
Conditions Studied
Interventions
- BEHAVIORAL Nutrition Education
- BEHAVIORAL EXCAP Exercise
Study Locations (2)
Maryland
- University of Maryland - Baltimore
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2025-08-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03858153
The ClinicalTrials.gov registry entry for NCT03858153 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 31-participant average among 6 other Neuropathy;Peripheral trials with a reported enrollment target (158% higher). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuropathy;Peripheral appearing as the primary indexed condition, and to 2 interventions - of which Nutrition Education is the first listed.
NCT03858153 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, New York.
Frequently Asked Questions
What is clinical trial NCT03858153 about?
NCT03858153 is a clinical study titled "Exercise and Nutrition Interventions During Chemotherapy K07". Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of taxane chemotherapy, often used to treat breast cancer. Unfortunately there are very limited treatments for CIPN. This is a phase II randomized controlled trial to test the preliminary efficacy of exerc...
What is the current status of trial NCT03858153?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2019-04-15. Estimated completion is 2025-08-27.
What conditions does trial NCT03858153 study?
This clinical trial studies the following conditions: Neuropathy;Peripheral.
What interventions are being tested in trial NCT03858153?
The interventions under investigation include: Nutrition Education (BEHAVIORAL), EXCAP Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03858153?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03858153 being conducted?
This trial has 2 study locations across Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathy;Peripheral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy
ACTIVE NOT RECRUITING · Phase 2
-
Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain
RECRUITING · NA
-
The Effect of Low Frequency Soundwave Stimulation on Chemotherapy Induced Peripheral Neuropathy
ACTIVE NOT RECRUITING · NA
-
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
ACTIVE NOT RECRUITING · NA
-
Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN)
COMPLETED · NA
-
BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.